메뉴 건너뛰기




Volumn 11, Issue 7, 2015, Pages 401-413

Interactions of the histamine and hypocretin systems in CNS disorders

Author keywords

[No Author keywords available]

Indexed keywords

ALPHA FLUOROMETHYLHISTIDINE; AMITRIPTYLINE; ANTIDEPRESSANT AGENT; ANTIHISTAMINIC AGENT; BROMPHENIRAMINE; CHLORPHENIRAMINE; DIPHENHYDRAMINE; DOXEPIN; DOXYLAMINE; HISTAMINE; HISTAMINE H1 RECEPTOR ANTAGONIST; HISTAMINE H3 RECEPTOR AGONIST; HISTAMINE H3 RECEPTOR ANTAGONIST; HISTAMINE RECEPTOR; MODAFINIL; NEUROLEPTIC AGENT; OLANZAPINE; OREXIN; PITOLISANT; PLACEBO; RISPERIDONE; HISTAMINE AGONIST;

EID: 84936847182     PISSN: 17594758     EISSN: 17594766     Source Type: Journal    
DOI: 10.1038/nrneurol.2015.99     Document Type: Review
Times cited : (84)

References (163)
  • 1
    • 84895302813 scopus 로고
    • Sleep as a problem of localization
    • von Economo, C. Sleep as a problem of localization. J. Nerv. Ment. Dis. 71, 249-259 (1930).
    • (1930) J. Nerv. Ment. Dis , vol.71 , pp. 249-259
    • Von Economo, C.1
  • 2
    • 0033826856 scopus 로고    scopus 로고
    • A mutation in a case of early onset narcolepsy and a generalized absence of hypocretin peptides in human narcoleptic brains
    • Peyron, C. et al. A mutation in a case of early onset narcolepsy and a generalized absence of hypocretin peptides in human narcoleptic brains. Nat. Med. 6, 991-997 (2000).
    • (2000) Nat. Med , vol.6 , pp. 991-997
    • Peyron, C.1
  • 3
    • 0033710848 scopus 로고    scopus 로고
    • Reduced number of hypocretin neurons in human narcolepsy
    • Thannickal, T. C. et al. Reduced number of hypocretin neurons in human narcolepsy. Neuron 27, 469-474 (2000).
    • (2000) Neuron , vol.27 , pp. 469-474
    • Thannickal, T.C.1
  • 5
    • 84892912382 scopus 로고    scopus 로고
    • Greatly increased numbers of histamine cells in human narcolepsy with cataplexy
    • John, J. et al. Greatly increased numbers of histamine cells in human narcolepsy with cataplexy. Ann. Neurol. 74, 786-793 (2013).
    • (2013) Ann. Neurol , vol.74 , pp. 786-793
    • John, J.1
  • 6
    • 84892147937 scopus 로고    scopus 로고
    • Increase of histaminergic tuberomammillary neurons in narcolepsy
    • Valko, P. O. et al. Increase of histaminergic tuberomammillary neurons in narcolepsy. Ann. Neurol. 74, 794-804 (2013).
    • (2013) Ann. Neurol , vol.74 , pp. 794-804
    • Valko, P.O.1
  • 7
  • 8
    • 84879367045 scopus 로고    scopus 로고
    • The histaminergic network in the brain: Basic organization and role in disease
    • Panula, P. & Nuutinen, S. The histaminergic network in the brain: basic organization and role in disease. Nat. Rev. Neurosci. 14, 472-487 (2013).
    • (2013) Nat. Rev. Neurosci , vol.14 , pp. 472-487
    • Panula, P.1    Nuutinen, S.2
  • 9
    • 84875134387 scopus 로고    scopus 로고
    • Human hypocretin and melanin-concentrating hormone levels are linked to emotion and social interaction
    • Blouin, A. M. et al. Human hypocretin and melanin-concentrating hormone levels are linked to emotion and social interaction. Nat. Commun. 4, 1547 (2013).
    • (2013) Nat. Commun , vol.4 , pp. 1547
    • Blouin, A.M.1
  • 10
    • 0036663072 scopus 로고    scopus 로고
    • Release of hypocretin (orexin) during waking and sleep states
    • Kiyashchenko, L. I. et al. Release of hypocretin (orexin) during waking and sleep states. J. Neurosci. 22, 5282-5286 (2002).
    • (2002) J. Neurosci , vol.22 , pp. 5282-5286
    • Kiyashchenko, L.I.1
  • 11
    • 80054885816 scopus 로고    scopus 로고
    • Highly specific role of hypocretin (orexin) neurons: Differential activation as a function of diurnal phase, operant reinforcement versus operant avoidance and light level
    • McGregor, R., Wu, M. F., Barber, G., Ramanathan, L. & Siegel, J. M. Highly specific role of hypocretin (orexin) neurons: differential activation as a function of diurnal phase, operant reinforcement versus operant avoidance and light level. J. Neurosci. 31, 15455-15467 (2011).
    • (2011) J. Neurosci , vol.31 , pp. 15455-15467
    • McGregor, R.1    Wu, M.F.2    Barber, G.3    Ramanathan, L.4    Siegel, J.M.5
  • 12
    • 19544376694 scopus 로고    scopus 로고
    • Behavioral correlates of activity in identified hypocretin/orexin neurons
    • Mileykovskiy, B. Y., Kiyashchenko, L. I. & Siegel, J. M. Behavioral correlates of activity in identified hypocretin/orexin neurons. Neuron 46, 787-798 (2005).
    • (2005) Neuron , vol.46 , pp. 787-798
    • Mileykovskiy, B.Y.1    Kiyashchenko, L.I.2    Siegel, J.M.3
  • 13
    • 0037036060 scopus 로고    scopus 로고
    • Co-localization of histamine with GABA but not with galanin in the human tuberomamillary nucleus
    • Trottier, S. et al. Co-localization of histamine with GABA but not with galanin in the human tuberomamillary nucleus. Brain Res. 939, 52-64 (2002).
    • (2002) Brain Res , vol.939 , pp. 52-64
    • Trottier, S.1
  • 14
    • 0023237751 scopus 로고
    • Morphological analysis of the tuberomammillary nucleus in the rat brain: Delineation of subgroups with antibody against l-histidine decarboxylase as a marker
    • Ericson, H., Watanabe, T. & Kohler, C. Morphological analysis of the tuberomammillary nucleus in the rat brain: delineation of subgroups with antibody against l-histidine decarboxylase as a marker. J. Comp. Neurol. 263, 1-24 (1987).
    • (1987) J. Comp. Neurol , vol.263 , pp. 1-24
    • Ericson, H.1    Watanabe, T.2    Kohler, C.3
  • 15
    • 0032526450 scopus 로고    scopus 로고
    • Innervation of histaminergic tuberomammillary neurons by GABAergic and galaninergic neurons in the ventrolateral preoptic nucleus of the rat
    • Sherin, J. E., Elmquist, J. K., Torrealba, F. & Saper, C. B. Innervation of histaminergic tuberomammillary neurons by GABAergic and galaninergic neurons in the ventrolateral preoptic nucleus of the rat. J. Neurosci. 18, 4705-4721 (1998).
    • (1998) J. Neurosci , vol.18 , pp. 4705-4721
    • Sherin, J.E.1    Elmquist, J.K.2    Torrealba, F.3    Saper, C.B.4
  • 16
    • 84866406441 scopus 로고    scopus 로고
    • GABAergic inhibition of histaminergic neurons regulates active waking but not the sleep-wake switch or propofol-induced loss of consciousness
    • Zecharia, A. Y. et al. GABAergic inhibition of histaminergic neurons regulates active waking but not the sleep-wake switch or propofol-induced loss of consciousness. J. Neurosci. 32, 13062-13075 (2012).
    • (2012) J. Neurosci , vol.32 , pp. 13062-13075
    • Zecharia, A.Y.1
  • 17
    • 84907158643 scopus 로고    scopus 로고
    • Caffeine promotes glutamate and histamine release in the posterior hypothalamus
    • John, J., Kodama, T. & Siegel, J. M. Caffeine promotes glutamate and histamine release in the posterior hypothalamus. Am. J. Physiol. Regul. Integr. Comp. Physiol. 307, R704-R710 (2014).
    • (2014) Am. J. Physiol. Regul. Integr. Comp. Physiol , vol.307 , pp. R704-R710
    • John, J.1    Kodama, T.2    Siegel, J.M.3
  • 18
    • 84919632372 scopus 로고    scopus 로고
    • Circadian factor BMAL1 in histaminergic neurons regulates sleep architecture
    • Yu, X. et al. Circadian factor BMAL1 in histaminergic neurons regulates sleep architecture. Curr. Biol. 24, 2838-2844 (2014).
    • (2014) Curr. Biol , vol.24 , pp. 2838-2844
    • Yu, X.1
  • 19
    • 77957922740 scopus 로고    scopus 로고
    • Expression patterns of corticotropin-releasing factor, arginine vasopressin, histidine decarboxylase, melanin-concentrating hormone, and orexin genes in the human hypothalamus
    • Krolewski, D. M. et al. Expression patterns of corticotropin-releasing factor, arginine vasopressin, histidine decarboxylase, melanin-concentrating hormone, and orexin genes in the human hypothalamus. J. Comp. Neurol. 518, 4591-4611 (2010).
    • (2010) J. Comp. Neurol , vol.518 , pp. 4591-4611
    • Krolewski, D.M.1
  • 20
    • 24344499528 scopus 로고    scopus 로고
    • The number of hypothalamic hypocretin (orexin) neurons is not affected in Prader-Willi syndrome
    • Fronczek, R., Lammers, G. J., Balesar, R., Unmehopa, U. A. & Swaab, D. F. The number of hypothalamic hypocretin (orexin) neurons is not affected in Prader-Willi syndrome. J. Clin. Endocrinol. Metab. 90, 5466-5470 (2005).
    • (2005) J. Clin. Endocrinol. Metab , vol.90 , pp. 5466-5470
    • Fronczek, R.1    Lammers, G.J.2    Balesar, R.3    Unmehopa, U.A.4    Swaab, D.F.5
  • 21
    • 20244380014 scopus 로고    scopus 로고
    • Orexins and orexin receptors: A family of hypothalamic neuropeptides and G protein-coupled receptors that regulate feeding behavior
    • Sakurai, T. et al. Orexins and orexin receptors: a family of hypothalamic neuropeptides and G protein-coupled receptors that regulate feeding behavior. Cell 92, 573-585 (1998).
    • (1998) Cell , vol.92 , pp. 573-585
    • Sakurai, T.1
  • 22
    • 4243302729 scopus 로고    scopus 로고
    • Orexin (hypocretin) neurons contain dynorphin
    • Chou, T. C. et al. Orexin (hypocretin) neurons contain dynorphin. J. Neurosci. 21, RC168 (2001).
    • (2001) J. Neurosci , vol.21 , pp. RC168
    • Chou, T.C.1
  • 23
    • 24944518715 scopus 로고    scopus 로고
    • Concomitant loss of dynorphin, NARP, and orexin in narcolepsy
    • Crocker, A. et al. Concomitant loss of dynorphin, NARP, and orexin in narcolepsy. Neurology 65, 1184-1188 (2005).
    • (2005) Neurology , vol.65 , pp. 1184-1188
    • Crocker, A.1
  • 24
    • 0038094513 scopus 로고    scopus 로고
    • Colocalization of orexin a and glutamate immunoreactivity in axon terminals in the tuberomammillary nucleus in rats
    • Torrealba, F., Yanagisawa, M. & Saper, C. B. Colocalization of orexin a and glutamate immunoreactivity in axon terminals in the tuberomammillary nucleus in rats. Neuroscience 119, 1033-1044 (2003).
    • (2003) Neuroscience , vol.119 , pp. 1033-1044
    • Torrealba, F.1    Yanagisawa, M.2    Saper, C.B.3
  • 25
    • 0036733218 scopus 로고    scopus 로고
    • Selective expression of Narp, a secreted neuronal pentraxin, in orexin neurons
    • Reti, I. M., Reddy, R., Worley, P. F. & Baraban, J. M. Selective expression of Narp, a secreted neuronal pentraxin, in orexin neurons. J. Neurochem. 82, 1561-1565 (2002).
    • (2002) J. Neurochem , vol.82 , pp. 1561-1565
    • Reti, I.M.1    Reddy, R.2    Worley, P.F.3    Baraban, J.M.4
  • 26
    • 24944512531 scopus 로고    scopus 로고
    • Narp immunostaining of human hypocretin (orexin) neurons: Loss in narcolepsy
    • Blouin, A. M. et al. Narp immunostaining of human hypocretin (orexin) neurons: loss in narcolepsy. Neurology 65, 1189-1192 (2005).
    • (2005) Neurology , vol.65 , pp. 1189-1192
    • Blouin, A.M.1
  • 27
    • 77957313794 scopus 로고    scopus 로고
    • Circadian and homeostatic regulation of structural synaptic plasticity in hypocretin neurons
    • Appelbaum, L. et al. Circadian and homeostatic regulation of structural synaptic plasticity in hypocretin neurons. Neuron 68, 87-98 (2010).
    • (2010) Neuron , vol.68 , pp. 87-98
    • Appelbaum, L.1
  • 28
    • 38049174218 scopus 로고    scopus 로고
    • Homer1a is a core brain molecular correlate of sleep loss
    • Maret, S. et al. Homer1a is a core brain molecular correlate of sleep loss. Proc. Natl Acad. Sci. USA 104, 20090-20095 (2007).
    • (2007) Proc. Natl Acad. Sci. USA , vol.104 , pp. 20090-20095
    • Maret, S.1
  • 29
    • 84899103938 scopus 로고    scopus 로고
    • Hypocretin (orexin) facilitates reward by attenuating the antireward effects of its cotransmitter dynorphin in ventral tegmental area
    • Muschamp, J. W. et al. Hypocretin (orexin) facilitates reward by attenuating the antireward effects of its cotransmitter dynorphin in ventral tegmental area. Proc. Natl Acad. Sci. USA 111, E1648-E1655 (2014).
    • (2014) Proc. Natl Acad. Sci. USA , vol.111 , pp. E1648-E1655
    • Muschamp, J.W.1
  • 30
    • 0036045943 scopus 로고    scopus 로고
    • Narcolepsy and psychopathology: Is there an association?
    • Vourdas, A. et al. Narcolepsy and psychopathology: is there an association? Sleep Med. 3, 353-360 (2002).
    • (2002) Sleep Med , vol.3 , pp. 353-360
    • Vourdas, A.1
  • 31
    • 0031283162 scopus 로고    scopus 로고
    • HLA DQB1 0602 is associated with cataplexy in 509 narcoleptic patients
    • Mignot, E., Hayduk, R., Black, J., Grumet, F. C. & Guilleminault, C. HLA DQB1 0602 is associated with cataplexy in 509 narcoleptic patients. Sleep 20, 1012-1020 (1997).
    • (1997) Sleep , vol.20 , pp. 1012-1020
    • Mignot, E.1    Hayduk, R.2    Black, J.3    Grumet, F.C.4    Guilleminault, C.5
  • 32
    • 84898684536 scopus 로고    scopus 로고
    • A mesoscale connectome of the mouse brain
    • Oh, S. W. et al. A mesoscale connectome of the mouse brain. Nature 508, 207-214 (2014).
    • (2014) Nature , vol.508 , pp. 207-214
    • Oh, S.W.1
  • 33
    • 0032402181 scopus 로고    scopus 로고
    • Neurons containing hypocretin (orexin) project to multiple neuronal systems
    • Peyron, C. et al. Neurons containing hypocretin (orexin) project to multiple neuronal systems. J. Neurosci. 18, 9996-10015 (1998).
    • (1998) J. Neurosci , vol.18 , pp. 9996-10015
    • Peyron, C.1
  • 34
    • 18444375874 scopus 로고    scopus 로고
    • Orexins activate histaminergic neurons via the orexin 2 receptor
    • Yamanaka, A. et al. Orexins activate histaminergic neurons via the orexin 2 receptor. Biochem. Biophys. Res. Commun. 290, 1237-1245 (2002).
    • (2002) Biochem. Biophys. Res. Commun , vol.290 , pp. 1237-1245
    • Yamanaka, A.1
  • 35
    • 0035859825 scopus 로고    scopus 로고
    • Arousal effect of orexin A depends on activation of the histaminergic system
    • Huang, Z. L. et al. Arousal effect of orexin A depends on activation of the histaminergic system. Proc. Natl Acad. Sci. USA 98, 9965-9970 (2001).
    • (2001) Proc. Natl Acad. Sci. USA , vol.98 , pp. 9965-9970
    • Huang, Z.L.1
  • 36
    • 0033588184 scopus 로고    scopus 로고
    • Narcolepsy in orexin knockout mice: Molecular genetics of sleep regulation
    • Chemelli, R. M. et al. Narcolepsy in orexin knockout mice: molecular genetics of sleep regulation. Cell 98, 437-451 (1999).
    • (1999) Cell , vol.98 , pp. 437-451
    • Chemelli, R.M.1
  • 37
    • 0035576310 scopus 로고    scopus 로고
    • Orexin/hypocretin excites the histaminergic neurons of the tuberomammillary nucleus
    • Eriksson, K. S., Sergeeva, O., Brown, R. E. & Haas, H. L. Orexin/hypocretin excites the histaminergic neurons of the tuberomammillary nucleus. J. Neurosci. 21, 9273-9279 (2001).
    • (2001) J. Neurosci , vol.21 , pp. 9273-9279
    • Eriksson, K.S.1    Sergeeva, O.2    Brown, R.E.3    Haas, H.L.4
  • 38
    • 84865717083 scopus 로고    scopus 로고
    • Optogenetic probing of fast glutamatergic transmission from hypocretin/orexin to histamine neurons situ
    • Schone, C. et al. Optogenetic probing of fast glutamatergic transmission from hypocretin/orexin to histamine neurons in situ. J. Neurosci. 32, 12437-12443 (2012).
    • (2012) J. Neurosci , vol.32 , pp. 12437-12443
    • Schone, C.1
  • 39
    • 82655181503 scopus 로고    scopus 로고
    • The histaminergic system regulates wakefulness and orexin/hypocretin neuron development via histamine receptor H1 in zebrafish
    • Sundvik, M. et al. The histaminergic system regulates wakefulness and orexin/hypocretin neuron development via histamine receptor H1 in zebrafish. FASEB J. 25, 4338-4347 (2011).
    • (2011) FASEB J , vol.25 , pp. 4338-4347
    • Sundvik, M.1
  • 40
    • 84894440343 scopus 로고    scopus 로고
    • Developmental roles of brain histamine
    • Panula, P., Sundvik, M. & Karlstedt, K. Developmental roles of brain histamine. Trends Neurosci. 37, 159-168 (2014).
    • (2014) Trends Neurosci , vol.37 , pp. 159-168
    • Panula, P.1    Sundvik, M.2    Karlstedt, K.3
  • 41
    • 84936845558 scopus 로고    scopus 로고
    • Interactions of the orexin/hypocretin neurones and the histaminergic system
    • Sundvik, M. & Panula, P. Interactions of the orexin/hypocretin neurones and the histaminergic system. Acta Physiol. (Oxf.) 213, 321-333 (2015).
    • (2015) Acta Physiol. (Oxf.) , vol.213 , pp. 321-333
    • Sundvik, M.1    Panula, P.2
  • 42
    • 20244374121 scopus 로고    scopus 로고
    • Input of orexin/hypocretin neurons revealed by a genetically encoded tracer in mice
    • Sakurai, T. et al. Input of orexin/hypocretin neurons revealed by a genetically encoded tracer in mice. Neuron 46, 297-308 (2005).
    • (2005) Neuron , vol.46 , pp. 297-308
    • Sakurai, T.1
  • 44
    • 0033523474 scopus 로고    scopus 로고
    • Sleep-waking discharge of neurons in the posterior lateral hypothalamus of the albino rat
    • Steininger, T. L., Alam, M. N., Gong, H., Szymusiak, R. & McGinty, D. Sleep-waking discharge of neurons in the posterior lateral hypothalamus of the albino rat. Brain Res. 840, 138-147 (1999).
    • (1999) Brain Res , vol.840 , pp. 138-147
    • Steininger, T.L.1    Alam, M.N.2    Gong, H.3    Szymusiak, R.4    McGinty, D.5
  • 45
    • 0033783643 scopus 로고    scopus 로고
    • Brain structures and mechanisms involved in the control of cortical activation and wakefulness, with emphasis on the posterior hypothalamus and histaminergic neurons
    • Lin, J. S. Brain structures and mechanisms involved in the control of cortical activation and wakefulness, with emphasis on the posterior hypothalamus and histaminergic neurons. Sleep Med. Rev. 4, 471-503 (2000).
    • (2000) Sleep Med. Rev , vol.4 , pp. 471-503
    • Lin, J.S.1
  • 46
    • 0036759585 scopus 로고    scopus 로고
    • Anatomical, physiological, and pharmacological characteristics of histidine decarboxylase knock-out mice: Evidence for the role of brain histamine in behavioral and sleep-wake control
    • Parmentier, R. et al. Anatomical, physiological, and pharmacological characteristics of histidine decarboxylase knock-out mice: evidence for the role of brain histamine in behavioral and sleep-wake control. J. Neurosci. 22, 7695-7711 (2002).
    • (2002) J. Neurosci , vol.22 , pp. 7695-7711
    • Parmentier, R.1
  • 47
    • 33645229309 scopus 로고    scopus 로고
    • Altered sleep-wake characteristics and lack of arousal response to H3 receptor antagonist in histamine H1 receptor knockout mice
    • Huang, Z. L. et al. Altered sleep-wake characteristics and lack of arousal response to H3 receptor antagonist in histamine H1 receptor knockout mice. Proc. Natl Acad. Sci. USA 103, 4687-4692 (2006).
    • (2006) Proc. Natl Acad. Sci. USA , vol.103 , pp. 4687-4692
    • Huang, Z.L.1
  • 48
    • 33751081248 scopus 로고    scopus 로고
    • Impaired ventilation and metabolism response to hypoxia in histamine H1 receptor-knockout mice
    • Ishiguro, T. et al. Impaired ventilation and metabolism response to hypoxia in histamine H1 receptor-knockout mice. Respir. Physiol. Neurobiol. 154, 331-341 (2006).
    • (2006) Respir. Physiol. Neurobiol , vol.154 , pp. 331-341
    • Ishiguro, T.1
  • 49
    • 84878528264 scopus 로고    scopus 로고
    • Enhanced histaminergic neurotransmission and sleep-wake alterations, a study in histamine H3-receptor knock-out mice
    • Gondard, E. et al. Enhanced histaminergic neurotransmission and sleep-wake alterations, a study in histamine H3-receptor knock-out mice. Neuropsychopharmacology 38, 1015-1031 (2013).
    • (2013) Neuropsychopharmacology , vol.38 , pp. 1015-1031
    • Gondard, E.1
  • 50
    • 0035834260 scopus 로고    scopus 로고
    • Decreased brain histamine content in hypocretin/orexin receptor-2 mutated narcoleptic dogs
    • Nishino, S. et al. Decreased brain histamine content in hypocretin/orexin receptor-2 mutated narcoleptic dogs. Neurosci. Lett. 313, 125-128 (2001).
    • (2001) Neurosci. Lett , vol.313 , pp. 125-128
    • Nishino, S.1
  • 51
    • 0035783672 scopus 로고    scopus 로고
    • Fluctuation of extracellular hypocretin-1 (orexin A) levels in the rat in relation to the light-dark cycle and sleep-wake activities
    • Yoshida, Y. et al. Fluctuation of extracellular hypocretin-1 (orexin A) levels in the rat in relation to the light-dark cycle and sleep-wake activities. Eur. J. Neurosci. 14, 1075-1081 (2001).
    • (2001) Eur. J. Neurosci , vol.14 , pp. 1075-1081
    • Yoshida, Y.1
  • 52
    • 70949083914 scopus 로고    scopus 로고
    • Orexin/hypocretin and histamine: Distinct roles in the control of wakefulness demonstrated using knock-out mouse models
    • Anaclet, C. et al. Orexin/hypocretin and histamine: distinct roles in the control of wakefulness demonstrated using knock-out mouse models. J. Neurosci. 29, 14423-14438 (2009).
    • (2009) J. Neurosci , vol.29 , pp. 14423-14438
    • Anaclet, C.1
  • 53
    • 84860630308 scopus 로고    scopus 로고
    • Diurnal fluctuation in histidine decarboxylase expression, the rate limiting enzyme for histamine production, and its disorder in neurodegenerative diseases
    • Shan, L. et al. Diurnal fluctuation in histidine decarboxylase expression, the rate limiting enzyme for histamine production, and its disorder in neurodegenerative diseases. Sleep 35, 713-715 (2012).
    • (2012) Sleep , vol.35 , pp. 713-715
    • Shan, L.1
  • 54
    • 84858794982 scopus 로고    scopus 로고
    • Time-course of cerebrospinal fluid histamine in the wake-consolidated squirrel monkey
    • Zeitzer, J. M. et al. Time-course of cerebrospinal fluid histamine in the wake-consolidated squirrel monkey. J. Sleep Res. 21, 189-194 (2012).
    • (2012) J. Sleep Res , vol.21 , pp. 189-194
    • Zeitzer, J.M.1
  • 55
    • 0028104597 scopus 로고
    • Diurnal and age-related changes in cerebrospinal fluid tele-methylhistamine levels during infancy and childhood
    • Kiviranta, T., Tuomisto, L. & Airaksinen, E. M. Diurnal and age-related changes in cerebrospinal fluid tele-methylhistamine levels during infancy and childhood. Pharmacol. Biochem. Behav. 49, 997-1000 (1994).
    • (1994) Pharmacol. Biochem. Behav , vol.49 , pp. 997-1000
    • Kiviranta, T.1    Tuomisto, L.2    Airaksinen, E.M.3
  • 56
    • 0038600674 scopus 로고    scopus 로고
    • Diurnal variation of cerebrospinal fluid hypocretin-1 (Orexin-A) levels in control and depressed subjects
    • Salomon, R. M. et al. Diurnal variation of cerebrospinal fluid hypocretin-1 (Orexin-A) levels in control and depressed subjects. Biol. Psychiatry 54, 96-104 (2003).
    • (2003) Biol. Psychiatry , vol.54 , pp. 96-104
    • Salomon, R.M.1
  • 57
    • 0036953356 scopus 로고    scopus 로고
    • Measurement of hypocretin/orexin content in the mouse brain using an enzyme immunoassay: The effect of circadian time, age and genetic background
    • Lin, L. et al. Measurement of hypocretin/orexin content in the mouse brain using an enzyme immunoassay: the effect of circadian time, age and genetic background. Peptides 23, 2203-2211 (2002).
    • (2002) Peptides , vol.23 , pp. 2203-2211
    • Lin, L.1
  • 59
    • 33846840794 scopus 로고    scopus 로고
    • Narcolepsy with cataplexy
    • Dauvilliers, Y., Arnulf, I. & Mignot, E. Narcolepsy with cataplexy. Lancet 369, 499-511 (2007).
    • (2007) Lancet , vol.369 , pp. 499-511
    • Dauvilliers, Y.1    Arnulf, I.2    Mignot, E.3
  • 60
    • 0035956531 scopus 로고    scopus 로고
    • CSF hypocretin/orexin levels in narcolepsy and other neurological conditions
    • Ripley, B. et al. CSF hypocretin/orexin levels in narcolepsy and other neurological conditions. Neurology 57, 2253-2258 (2001).
    • (2001) Neurology , vol.57 , pp. 2253-2258
    • Ripley, B.1
  • 61
    • 0036791834 scopus 로고    scopus 로고
    • The role of cerebrospinal fluid hypocretin measurement in the diagnosis of narcolepsy and other hypersomnias
    • Mignot, E. et al. The role of cerebrospinal fluid hypocretin measurement in the diagnosis of narcolepsy and other hypersomnias. Arch. Neurol. 59, 1553-1562 (2002).
    • (2002) Arch. Neurol , vol.59 , pp. 1553-1562
    • Mignot, E.1
  • 63
    • 70349143485 scopus 로고    scopus 로고
    • Localized loss of hypocretin (orexin) cells in narcolepsy without cataplexy
    • Thannickal, T. C., Nienhuis, R. & Siegel, J. M. Localized loss of hypocretin (orexin) cells in narcolepsy without cataplexy. Sleep 32, 993-998 (2009).
    • (2009) Sleep , vol.32 , pp. 993-998
    • Thannickal, T.C.1    Nienhuis, R.2    Siegel, J.M.3
  • 64
    • 59649094276 scopus 로고    scopus 로고
    • A consensus definition of cataplexy in mouse models of narcolepsy
    • International Working Group on Rodent Models of, N.
    • Scammell, T. E., Willie, J. T., Guilleminault, C., Siegel, J. M. & International Working Group on Rodent Models of, N. A consensus definition of cataplexy in mouse models of narcolepsy. Sleep 32, 111-116 (2009).
    • (2009) Sleep , vol.32 , pp. 111-116
    • Scammell, T.E.1    Willie, J.T.2    Guilleminault, C.3    Siegel, J.M.4
  • 65
    • 62549119555 scopus 로고    scopus 로고
    • Decreased CSF histamine in narcolepsy with and without low CSF hypocretin-1 in comparison to healthy controls
    • Nishino, S. et al. Decreased CSF histamine in narcolepsy with and without low CSF hypocretin-1 in comparison to healthy controls. Sleep 32, 175-180 (2009).
    • (2009) Sleep , vol.32 , pp. 175-180
    • Nishino, S.1
  • 66
    • 0032951843 scopus 로고    scopus 로고
    • Locus coeruleus neurons: Cessation of activity during cataplexy
    • Wu, M. F. et al. Locus coeruleus neurons: cessation of activity during cataplexy. Neuroscience 91, 1389-1399 (1999).
    • (1999) Neuroscience , vol.91 , pp. 1389-1399
    • Wu, M.F.1
  • 67
    • 0026434566 scopus 로고
    • Neuronal activity in narcolepsy: Identification of cataplexy-related cells in the medial medulla
    • Siegel, J. M. et al. Neuronal activity in narcolepsy: identification of cataplexy-related cells in the medial medulla. Science 252, 1315-1318 (1991).
    • (1991) Science , vol.252 , pp. 1315-1318
    • Siegel, J.M.1
  • 68
    • 2442544417 scopus 로고    scopus 로고
    • Cataplexy-Active neurons in the hypothalamus: Implications for the role of histamine in sleep and waking behavior
    • John, J., Wu, M. F., Boehmer, L. N. & Siegel, J. M. Cataplexy-Active neurons in the hypothalamus: implications for the role of histamine in sleep and waking behavior. Neuron 42, 619-634 (2004).
    • (2004) Neuron , vol.42 , pp. 619-634
    • John, J.1    Wu, M.F.2    Boehmer, L.N.3    Siegel, J.M.4
  • 70
    • 84899855138 scopus 로고    scopus 로고
    • Conditional ablation of orexin/hypocretin neurons: A new mouse model for the study of narcolepsy and orexin system function
    • Tabuchi, S. et al. Conditional ablation of orexin/hypocretin neurons: a new mouse model for the study of narcolepsy and orexin system function. J. Neurosci. 34, 6495-6509 (2014).
    • (2014) J. Neurosci , vol.34 , pp. 6495-6509
    • Tabuchi, S.1
  • 71
    • 84867045078 scopus 로고    scopus 로고
    • Normal cerebrospinal fluid histamine and tele-methylhistamine levels in hypersomnia conditions
    • Dauvilliers, Y. et al. Normal cerebrospinal fluid histamine and tele-methylhistamine levels in hypersomnia conditions. Sleep 35, 1359-1366 (2012).
    • (2012) Sleep , vol.35 , pp. 1359-1366
    • Dauvilliers, Y.1
  • 72
    • 77951891860 scopus 로고    scopus 로고
    • Narcolepsy: Autoimmunity, effector T cell activation due to infection, or T cell independent, major histocompatibility complex class II induced neuronal loss?
    • Fontana, A. et al. Narcolepsy: autoimmunity, effector T cell activation due to infection, or T cell independent, major histocompatibility complex class II induced neuronal loss? Brain 133, 1300-1311 (2010).
    • (2010) Brain , vol.133 , pp. 1300-1311
    • Fontana, A.1
  • 73
    • 70349161242 scopus 로고    scopus 로고
    • Elevated anti-streptococcal antibodies in patients with recent narcolepsy onset
    • Aran, A. et al. Elevated anti-streptococcal antibodies in patients with recent narcolepsy onset. Sleep 32, 979-983 (2009).
    • (2009) Sleep , vol.32 , pp. 979-983
    • Aran, A.1
  • 74
    • 84880943684 scopus 로고    scopus 로고
    • Increased risk of narcolepsy in children and adults after pandemic H1N1 vaccination in France
    • Dauvilliers, Y. et al. Increased risk of narcolepsy in children and adults after pandemic H1N1 vaccination in France. Brain 136, 2486-2496 (2013).
    • (2013) Brain , vol.136 , pp. 2486-2496
    • Dauvilliers, Y.1
  • 75
    • 84901000625 scopus 로고    scopus 로고
    • Narcolepsy as an autoimmune disease: The role of H1N1 infection and vaccination
    • Partinen, M. et al. Narcolepsy as an autoimmune disease: the role of H1N1 infection and vaccination. Lancet Neurol. 13, 600-613 (2014).
    • (2014) Lancet Neurol , vol.13 , pp. 600-613
    • Partinen, M.1
  • 76
    • 84907228036 scopus 로고    scopus 로고
    • Narcolepsy patients have antibodies that stain distinct cell populations in rat brain and influence sleep patterns
    • Bergman, P. et al. Narcolepsy patients have antibodies that stain distinct cell populations in rat brain and influence sleep patterns. Proc. Natl Acad. Sci. USA 111, E3735-E3744 (2014).
    • (2014) Proc. Natl Acad. Sci. USA , vol.111 , pp. E3735-E3744
    • Bergman, P.1
  • 77
    • 77949667777 scopus 로고    scopus 로고
    • Elevated Tribbles homolog 2-specific antibody levels in narcolepsy patients
    • Cvetkovic-Lopes, V. et al. Elevated Tribbles homolog 2-specific antibody levels in narcolepsy patients. J. Clin. Invest. 120, 713-719 (2010).
    • (2010) J. Clin. Invest , vol.120 , pp. 713-719
    • Cvetkovic-Lopes, V.1
  • 78
    • 0042380071 scopus 로고    scopus 로고
    • Involvement of both 'allergic' and 'autoimmune' mechanisms in EAE, MS and other autoimmune diseases
    • Pedotti, R., De Voss, J. J., Steinman, L. & Galli, S. J. Involvement of both 'allergic' and 'autoimmune' mechanisms in EAE, MS and other autoimmune diseases. Trends Immunol. 24, 479-484 (2003).
    • (2003) Trends Immunol , vol.24 , pp. 479-484
    • Pedotti, R.1    De Voss, J.J.2    Steinman, L.3    Galli, S.J.4
  • 79
    • 33645014201 scopus 로고    scopus 로고
    • Allergy, histamine 1 receptor blockers, and the risk of multiple sclerosis
    • Alonso, A., Jick, S. S. & Hernan, M. A. Allergy, histamine 1 receptor blockers, and the risk of multiple sclerosis. Neurology 66, 572-575 (2006).
    • (2006) Neurology , vol.66 , pp. 572-575
    • Alonso, A.1    Jick, S.S.2    Hernan, M.A.3
  • 80
    • 0036105484 scopus 로고    scopus 로고
    • Gene-microarray analysis of multiple sclerosis lesions yields new targets validated in autoimmune encephalomyelitis
    • Lock, C. et al. Gene-microarray analysis of multiple sclerosis lesions yields new targets validated in autoimmune encephalomyelitis. Nat. Med. 8, 500-508 (2002).
    • (2002) Nat. Med , vol.8 , pp. 500-508
    • Lock, C.1
  • 81
    • 84904546753 scopus 로고    scopus 로고
    • Hypocretin and brain beta-Amyloid peptide interactions in cognitive disorders and narcolepsy. Front
    • Dauvilliers, Y. A., Lehmann, S., Jaussent, I. & Gabelle, A. Hypocretin and brain beta-Amyloid peptide interactions in cognitive disorders and narcolepsy. Front. Aging Neurosci. 6, 119 (2014).
    • (2014) Aging Neurosci , vol.6 , pp. 119
    • Dauvilliers, Y.A.1    Lehmann, S.2    Jaussent, I.3    Gabelle, A.4
  • 82
    • 0037882036 scopus 로고    scopus 로고
    • Optic neuritis, a new variant of experimental encephalomyelitis, a durable model for all seasons, now in its seventieth year
    • Steinman, L. Optic neuritis, a new variant of experimental encephalomyelitis, a durable model for all seasons, now in its seventieth year. J. Exp. Med. 197, 1065-1071 (2003).
    • (2003) J. Exp. Med , vol.197 , pp. 1065-1071
    • Steinman, L.1
  • 83
    • 0035554898 scopus 로고    scopus 로고
    • Multiple sclerosis: A two-stage disease
    • Steinman, L. Multiple sclerosis: a two-stage disease. Nat. Immunol. 2, 762-764 (2001).
    • (2001) Nat. Immunol , vol.2 , pp. 762-764
    • Steinman, L.1
  • 85
    • 34547142877 scopus 로고    scopus 로고
    • Central histamine H3 receptor signaling negatively regulates susceptibility to autoimmune inflammatory disease of the CNS
    • Teuscher, C. et al. Central histamine H3 receptor signaling negatively regulates susceptibility to autoimmune inflammatory disease of the CNS. Proc. Natl Acad. Sci. USA 104, 10146-10151 (2007).
    • (2007) Proc. Natl Acad. Sci. USA , vol.104 , pp. 10146-10151
    • Teuscher, C.1
  • 86
    • 0023917761 scopus 로고
    • Regulation of glycogenolysis by neurotransmitters in the central nervous system
    • Magistretti, P. J. Regulation of glycogenolysis by neurotransmitters in the central nervous system. Diabete. Metab. 14, 237-246 (1988).
    • (1988) Diabete Metab , vol.14 , pp. 237-246
    • Magistretti, P.J.1
  • 87
    • 84901602241 scopus 로고    scopus 로고
    • Increased cerebrospinal fluid levels of nerve cell biomarkers in narcolepsy with cataplexy
    • Heier, M. S., Skinningsrud, A., Paus, E. & Gautvik, K. M. Increased cerebrospinal fluid levels of nerve cell biomarkers in narcolepsy with cataplexy. Sleep Med. 15, 614-618 (2014).
    • (2014) Sleep Med , vol.15 , pp. 614-618
    • Heier, M.S.1    Skinningsrud, A.2    Paus, E.3    Gautvik, K.M.4
  • 88
    • 0035959904 scopus 로고    scopus 로고
    • Histamine regulates T-cell and antibody responses by differential expression of H1 and H2 receptors
    • Jutel, M. et al. Histamine regulates T-cell and antibody responses by differential expression of H1 and H2 receptors. Nature 413, 420-425 (2001).
    • (2001) Nature , vol.413 , pp. 420-425
    • Jutel, M.1
  • 90
    • 84885803725 scopus 로고    scopus 로고
    • Histamine from brain resident MAST cells promotes wakefulness and modulates behavioral states
    • Chikahisa, S. et al. Histamine from brain resident MAST cells promotes wakefulness and modulates behavioral states. PLoS ONE 8, e78434 (2013).
    • (2013) PLoS ONE , vol.8 , pp. e78434
    • Chikahisa, S.1
  • 92
    • 84880813336 scopus 로고    scopus 로고
    • Nitric oxide mediates selective degeneration of hypothalamic orexin neurons through dysfunction of protein disulfide isomerase
    • Obukuro, K. et al. Nitric oxide mediates selective degeneration of hypothalamic orexin neurons through dysfunction of protein disulfide isomerase. J. Neurosci. 33, 12557-12568 (2013).
    • (2013) J. Neurosci , vol.33 , pp. 12557-12568
    • Obukuro, K.1
  • 93
    • 0035123904 scopus 로고    scopus 로고
    • Kynurenines in the CNS: From endogenous obscurity to therapeutic importance
    • Stone, T. W. Kynurenines in the CNS: from endogenous obscurity to therapeutic importance. Prog. Neurobiol. 64, 185-218 (2001).
    • (2001) Prog. Neurobiol , vol.64 , pp. 185-218
    • Stone, T.W.1
  • 94
    • 1642497595 scopus 로고    scopus 로고
    • Excitotoxic degeneration of hypothalamic orexin neurons in slice culture
    • Katsuki, H. & Akaike, A. Excitotoxic degeneration of hypothalamic orexin neurons in slice culture. Neurobiol. Dis. 15, 61-69 (2004).
    • (2004) Neurobiol. Dis , vol.15 , pp. 61-69
    • Katsuki, H.1    Akaike, A.2
  • 95
    • 84924578659 scopus 로고    scopus 로고
    • The human histaminergic system in neuropsychiatric disorders
    • Shan, L., Bao, A. M. & Swaab, D. F. The human histaminergic system in neuropsychiatric disorders. Trends Neurosci. 38, 167-177 (2015).
    • (2015) Trends Neurosci , vol.38 , pp. 167-177
    • Shan, L.1    Bao, A.M.2    Swaab, D.F.3
  • 96
    • 0034122975 scopus 로고    scopus 로고
    • An altered histaminergic innervation of the substantia nigra in Parkinson's disease
    • Anichtchik, O. V., Rinne, J. O., Kalimo, H. & Panula, P. An altered histaminergic innervation of the substantia nigra in Parkinson's disease. Exp. Neurol. 163, 20-30 (2000).
    • (2000) Exp. Neurol , vol.163 , pp. 20-30
    • Anichtchik, O.V.1    Rinne, J.O.2    Kalimo, H.3    Panula, P.4
  • 97
    • 0036319037 scopus 로고    scopus 로고
    • Increased brain histamine levels in Parkinson's disease but not in multiple system atrophy
    • Rinne, J. O. et al. Increased brain histamine levels in Parkinson's disease but not in multiple system atrophy. J. Neurochem. 81, 954-960 (2002).
    • (2002) J. Neurochem , vol.81 , pp. 954-960
    • Rinne, J.O.1
  • 98
    • 35548944382 scopus 로고    scopus 로고
    • Involvement of brain endogenous histamine in the degeneration of dopaminergic neurons in 6-hydroxydopamine-lesioned rats
    • Liu, C. Q., Chen, Z., Liu, F. X., Hu, D. N. & Luo, J. H. Involvement of brain endogenous histamine in the degeneration of dopaminergic neurons in 6-hydroxydopamine-lesioned rats. Neuropharmacology 53, 832-841 (2007).
    • (2007) Neuropharmacology , vol.53 , pp. 832-841
    • Liu, C.Q.1    Chen, Z.2    Liu, F.X.3    Hu, D.N.4    Luo, J.H.5
  • 99
    • 44649118525 scopus 로고    scopus 로고
    • Apomorphine-induced turning behavior in 6-hydroxydopamine lesioned rats is increased by histidine and decreased by histidine decarboxylase, histamine H1 and H2 receptor antagonists, and an H3 receptor agonist
    • Liu, C. Q., Hu, D. N., Liu, F. X., Chen, Z. & Luo, J. H. Apomorphine-induced turning behavior in 6-hydroxydopamine lesioned rats is increased by histidine and decreased by histidine decarboxylase, histamine H1 and H2 receptor antagonists, and an H3 receptor agonist. Pharmacol. Biochem. Behav. 90, 325-330 (2008).
    • (2008) Pharmacol. Biochem. Behav , vol.90 , pp. 325-330
    • Liu, C.Q.1    Hu, D.N.2    Liu, F.X.3    Chen, Z.4    Luo, J.H.5
  • 100
    • 84884856741 scopus 로고    scopus 로고
    • Alzheimer's disease clinical and research update for health care practitioners
    • Defina, P. A., Moser, R. S., Glenn, M., Lichtenstein, J. D. & Fellus, J. Alzheimer's disease clinical and research update for health care practitioners. J. Aging Res. 2013, 207178 (2013).
    • (2013) J. Aging Res , vol.2013 , pp. 207178
    • Defina, P.A.1    Moser, R.S.2    Glenn, M.3    Lichtenstein, J.D.4    Fellus, J.5
  • 101
    • 0033647048 scopus 로고    scopus 로고
    • Circadian and sleep disturbances in the elderly
    • Van Someren, E. J. Circadian and sleep disturbances in the elderly. Exp. Gerontol. 35, 1229-1237 (2000).
    • (2000) Exp. Gerontol , vol.35 , pp. 1229-1237
    • Van Someren, E.J.1
  • 102
    • 0028905719 scopus 로고
    • Predictors of mortality and institutionalization in Alzheimer disease patients 1 year after discharge from an Alzheimer dementia unit
    • Bianchetti, A. et al. Predictors of mortality and institutionalization in Alzheimer disease patients 1 year after discharge from an Alzheimer dementia unit. Dementia 6, 108-112 (1995).
    • (1995) Dementia , vol.6 , pp. 108-112
    • Bianchetti, A.1
  • 103
    • 0027490614 scopus 로고
    • Staging of Alzheimer-related cortical destruction
    • Braak, H., Braak, E. & Bohl, J. Staging of Alzheimer-related cortical destruction. Eur. Neurol. 33, 403-408 (1993).
    • (1993) Eur. Neurol , vol.33 , pp. 403-408
    • Braak, H.1    Braak, E.2    Bohl, J.3
  • 104
    • 84879029748 scopus 로고    scopus 로고
    • Neuronal histaminergic system in aging and age-related neurodegenerative disorders
    • Shan, L., Swaab, D. F. & Bao, A. M. Neuronal histaminergic system in aging and age-related neurodegenerative disorders. Exp. Gerontol. 48, 603-607 (2013).
    • (2013) Exp. Gerontol , vol.48 , pp. 603-607
    • Shan, L.1    Swaab, D.F.2    Bao, A.M.3
  • 105
    • 84918549525 scopus 로고    scopus 로고
    • Orexinergic system dysregulation, sleep impairment, and cognitive decline in Alzheimer disease
    • Liguori, C. et al. Orexinergic system dysregulation, sleep impairment, and cognitive decline in Alzheimer disease. JAMA Neurol. 71, 1498-1505 (2014).
    • (2014) JAMA Neurol , vol.71 , pp. 1498-1505
    • Liguori, C.1
  • 106
    • 72449161215 scopus 로고    scopus 로고
    • Amyloid-β dynamics are regulated by orexin and the sleep-wake cycle
    • Kang, J. E. et al. Amyloid-β dynamics are regulated by orexin and the sleep-wake cycle. Science 326, 1005-1007 (2009).
    • (2009) Science , vol.326 , pp. 1005-1007
    • Kang, J.E.1
  • 108
    • 84861881414 scopus 로고    scopus 로고
    • Hypocretin (orexin) loss in Alzheimer's disease
    • Fronczek, R. et al. Hypocretin (orexin) loss in Alzheimer's disease. Neurobiol. Aging 33, 1642-1650 (2012).
    • (2012) Neurobiol. Aging , vol.33 , pp. 1642-1650
    • Fronczek, R.1
  • 109
    • 0025742992 scopus 로고
    • Histamine neurons in human hypothalamus: Anatomy in normal and Alzheimer diseased brains
    • Airaksinen, M. S. et al. Histamine neurons in human hypothalamus: anatomy in normal and Alzheimer diseased brains. Neuroscience 44, 465-481 (1991).
    • (1991) Neuroscience , vol.44 , pp. 465-481
    • Airaksinen, M.S.1
  • 110
    • 84865606992 scopus 로고    scopus 로고
    • Alterations in the histaminergic system in Alzheimer's disease: A postmortem study
    • Shan, L., Bossers, K., Unmehopa, U., Bao, A. M. & Swaab, D. F. Alterations in the histaminergic system in Alzheimer's disease: a postmortem study. Neurobiol. Aging 33, 2585-2598 (2012).
    • (2012) Neurobiol. Aging , vol.33 , pp. 2585-2598
    • Shan, L.1    Bossers, K.2    Unmehopa, U.3    Bao, A.M.4    Swaab, D.F.5
  • 111
    • 78650646498 scopus 로고    scopus 로고
    • CSF levels of the histamine metabolite tele-methylhistamine are only slightly decreased in Alzheimer's disease
    • Motawaj, M., Peoc'h, K., Callebert, J. & Arrang, J. M. CSF levels of the histamine metabolite tele-methylhistamine are only slightly decreased in Alzheimer's disease. J. Alzheimers Dis. 22, 861-871 (2010).
    • (2010) J. Alzheimers Dis , vol.22 , pp. 861-871
    • Motawaj, M.1    Peoc'h, K.2    Callebert, J.3    Arrang, J.M.4
  • 112
    • 0032924926 scopus 로고    scopus 로고
    • Increased activity of surviving locus ceruleus neurons in Alzheimer's disease
    • Hoogendijk, W. J. et al. Increased activity of surviving locus ceruleus neurons in Alzheimer's disease. Ann. Neurol. 45, 82-91 (1999).
    • (1999) Ann. Neurol , vol.45 , pp. 82-91
    • Hoogendijk, W.J.1
  • 113
    • 32544460565 scopus 로고    scopus 로고
    • Compensatory changes in the noradrenergic nervous system in the locus ceruleus and hippocampus of postmortem subjects with Alzheimer's disease and dementia with Lewy bodies
    • Szot, P. et al. Compensatory changes in the noradrenergic nervous system in the locus ceruleus and hippocampus of postmortem subjects with Alzheimer's disease and dementia with Lewy bodies. J. Neurosci. 26, 467-478 (2006).
    • (2006) J. Neurosci , vol.26 , pp. 467-478
    • Szot, P.1
  • 114
    • 79954421304 scopus 로고    scopus 로고
    • Histamine receptors in the CNS as targets for therapeutic intervention
    • Passani, M. B. & Blandina, P. Histamine receptors in the CNS as targets for therapeutic intervention. Trends Pharmacol. Sci. 32, 242-249 (2011).
    • (2011) Trends Pharmacol. Sci , vol.32 , pp. 242-249
    • Passani, M.B.1    Blandina, P.2
  • 115
    • 84860538199 scopus 로고    scopus 로고
    • Pilot randomized controlled study of a histamine receptor inverse agonist in the symptomatic treatment of AD
    • Egan, M. et al. Pilot randomized controlled study of a histamine receptor inverse agonist in the symptomatic treatment of AD. Curr. Alzheimer Res. 9, 481-490 (2012).
    • (2012) Curr. Alzheimer Res , vol.9 , pp. 481-490
    • Egan, M.1
  • 116
    • 84907150288 scopus 로고    scopus 로고
    • A randomized study of H3 antagonist ABT-288 in mild-to-moderate Alzheimer's dementia
    • Haig, G. M. et al. A randomized study of H3 antagonist ABT-288 in mild-to-moderate Alzheimer's dementia. J. Alzheimers Dis. 42, 959-971 (2014).
    • (2014) J. Alzheimers Dis , vol.42 , pp. 959-971
    • Haig, G.M.1
  • 117
    • 84891763528 scopus 로고    scopus 로고
    • A randomized, double-blind, placebo-controlled, 16-week study of the H3 receptor antagonist, GSK239512 as a monotherapy in subjects with mild-to-moderate Alzheimer's disease
    • Grove, R. A. et al. A randomized, double-blind, placebo-controlled, 16-week study of the H3 receptor antagonist, GSK239512 as a monotherapy in subjects with mild-to-moderate Alzheimer's disease. Curr. Alzheimer Res. 11, 47-58 (2014).
    • (2014) Curr. Alzheimer Res , vol.11 , pp. 47-58
    • Grove, R.A.1
  • 118
    • 34247631275 scopus 로고    scopus 로고
    • Multiple hit hypotheses for dopamine neuron loss in Parkinson's disease
    • Sulzer, D. Multiple hit hypotheses for dopamine neuron loss in Parkinson's disease. Trends Neurosci. 30, 244-250 (2007).
    • (2007) Trends Neurosci , vol.30 , pp. 244-250
    • Sulzer, D.1
  • 119
    • 0037333666 scopus 로고    scopus 로고
    • Staging of brain pathology related to sporadic Parkinson's disease
    • Braak, H. et al. Staging of brain pathology related to sporadic Parkinson's disease. Neurobiol. Aging 24, 197-211 (2003).
    • (2003) Neurobiol. Aging , vol.24 , pp. 197-211
    • Braak, H.1
  • 121
    • 0037160563 scopus 로고    scopus 로고
    • Excessive daytime sleepiness and sudden-onset sleep in Parkinson disease: A survey by the Canadian Movement Disorders Group
    • Hobson, D. E. et al. Excessive daytime sleepiness and sudden-onset sleep in Parkinson disease: a survey by the Canadian Movement Disorders Group. JAMA 287, 455-463 (2002).
    • (2002) JAMA , vol.287 , pp. 455-463
    • Hobson, D.E.1
  • 122
    • 27644439093 scopus 로고    scopus 로고
    • Excessive daytime sleepiness and subsequent development of Parkinson disease
    • Abbott, R. D. et al. Excessive daytime sleepiness and subsequent development of Parkinson disease. Neurology 65, 1442-1446 (2005).
    • (2005) Neurology , vol.65 , pp. 1442-1446
    • Abbott, R.D.1
  • 123
    • 18844365394 scopus 로고    scopus 로고
    • Excessive daytime sleepiness in parkinsonism
    • Arnulf, I. Excessive daytime sleepiness in parkinsonism. Sleep Med. Rev. 9, 185-200 (2005).
    • (2005) Sleep Med. Rev , vol.9 , pp. 185-200
    • Arnulf, I.1
  • 124
    • 0037046219 scopus 로고    scopus 로고
    • Parkinson's disease and sleepiness: An integral part of PD
    • Arnulf, I. et al. Parkinson's disease and sleepiness: an integral part of PD. Neurology 58, 1019-1024 (2002).
    • (2002) Neurology , vol.58 , pp. 1019-1024
    • Arnulf, I.1
  • 125
    • 84910593982 scopus 로고    scopus 로고
    • Daytime sleepiness in Parkinson's disease: A reappraisal
    • Cochen De Cock, V. et al. Daytime sleepiness in Parkinson's disease: a reappraisal. PLoS ONE 9, e107278 (2014).
    • (2014) PLoS ONE , vol.9 , pp. e107278
    • Cochen De Cock, V.1
  • 126
    • 37549059091 scopus 로고    scopus 로고
    • Hypocretin (orexin) and melanin concentrating hormone loss and the symptoms of Parkinson's disease
    • Thannickal, T. C., Lai, Y. Y. & Siegel, J. M. Hypocretin (orexin) and melanin concentrating hormone loss and the symptoms of Parkinson's disease. Brain 131, e87 (2008).
    • (2008) Brain , vol.131 , pp. e87
    • Thannickal, T.C.1    Lai, Y.Y.2    Siegel, J.M.3
  • 127
    • 34250841699 scopus 로고    scopus 로고
    • Hypocretin (orexin) loss in Parkinson's disease
    • Fronczek, R. et al. Hypocretin (orexin) loss in Parkinson's disease. Brain 130, 1577-1585 (2007).
    • (2007) Brain , vol.130 , pp. 1577-1585
    • Fronczek, R.1
  • 128
    • 0042432035 scopus 로고    scopus 로고
    • Low levels of ventricular CSF orexin/hypocretin in advanced PD
    • Drouot, X. et al. Low levels of ventricular CSF orexin/hypocretin in advanced PD. Neurology 61, 540-543 (2003).
    • (2003) Neurology , vol.61 , pp. 540-543
    • Drouot, X.1
  • 129
    • 0037065792 scopus 로고    scopus 로고
    • Normal hypocretin-1 levels in Parkinson's disease patients with excessive daytime sleepiness
    • Overeem, S. et al. Normal hypocretin-1 levels in Parkinson's disease patients with excessive daytime sleepiness. Neurology 58, 498-499 (2002).
    • (2002) Neurology , vol.58 , pp. 498-499
    • Overeem, S.1
  • 130
    • 72649095340 scopus 로고    scopus 로고
    • Cerebrospinal hypocretin, daytime sleepiness and sleep architecture in Parkinson's disease dementia
    • Compta, Y. et al. Cerebrospinal hypocretin, daytime sleepiness and sleep architecture in Parkinson's disease dementia. Brain 132, 3308-3317 (2009).
    • (2009) Brain , vol.132 , pp. 3308-3317
    • Compta, Y.1
  • 131
    • 84861184163 scopus 로고    scopus 로고
    • Neuronal histamine production remains unaltered in Parkinson's disease despite the accumulation of Lewy bodies and Lewy neurites in the tuberomamillary nucleus
    • Shan, L. et al. Neuronal histamine production remains unaltered in Parkinson's disease despite the accumulation of Lewy bodies and Lewy neurites in the tuberomamillary nucleus. Neurobiol. Aging 33, 1343-1344 (2012).
    • (2012) Neurobiol. Aging , vol.33 , pp. 1343-1344
    • Shan, L.1
  • 132
    • 0029991711 scopus 로고    scopus 로고
    • Large neurons in the tuberomammillary nucleus in patients with Parkinson's disease and multiple system atrophy
    • Nakamura, S. et al. Large neurons in the tuberomammillary nucleus in patients with Parkinson's disease and multiple system atrophy. Neurology 46, 1693-1696 (1996).
    • (1996) Neurology , vol.46 , pp. 1693-1696
    • Nakamura, S.1
  • 133
    • 0020684289 scopus 로고
    • Brain histidine decarboxylase activity in Parkinson's disease
    • Garbarg, M., Javoy-Agid, F., Schwartz, J. C. & Agid, Y. Brain histidine decarboxylase activity in Parkinson's disease. Lancet 1, 74-75 (1983).
    • (1983) Lancet , vol.1 , pp. 74-75
    • Garbarg, M.1    Javoy-Agid, F.2    Schwartz, J.C.3    Agid, Y.4
  • 134
    • 0025743723 scopus 로고
    • Histamine metabolites and pros-methylimidazoleacetic acid in human cerebrospinal fluid
    • Prell, G. D. & Green, J. P. Histamine metabolites and pros-methylimidazoleacetic acid in human cerebrospinal fluid. Agents Actions Suppl. 33, 343-363 (1991).
    • (1991) Agents Actions Suppl , vol.33 , pp. 343-363
    • Prell, G.D.1    Green, J.P.2
  • 135
    • 53049084348 scopus 로고    scopus 로고
    • The current clinical management of Huntington's disease
    • Phillips, W., Shannon, K. M. & Barker, R. A. The current clinical management of Huntington's disease. Mov. Disord. 23, 1491-1504 (2008).
    • (2008) Mov. Disord , vol.23 , pp. 1491-1504
    • Phillips, W.1    Shannon, K.M.2    Barker, R.A.3
  • 136
    • 0028316870 scopus 로고
    • A worldwide study of the Huntington's disease mutation. The sensitivity and specificity of measuring CAG repeats
    • Kremer, B. et al. A worldwide study of the Huntington's disease mutation. The sensitivity and specificity of measuring CAG repeats. N. Engl. J. Med. 330, 1401-1406 (1994).
    • (1994) N. Engl. J. Med , vol.330 , pp. 1401-1406
    • Kremer, B.1
  • 137
    • 51249102726 scopus 로고    scopus 로고
    • Hypocretin and melanin-concentrating hormone in patients with Huntington disease
    • Aziz, A. et al. Hypocretin and melanin-concentrating hormone in patients with Huntington disease. Brain Pathol. 18, 474-483 (2008).
    • (2008) Brain Pathol , vol.18 , pp. 474-483
    • Aziz, A.1
  • 138
    • 36549030256 scopus 로고    scopus 로고
    • Hypothalamic dysfunction and neuroendocrine and metabolic alterations in Huntington's disease: Clinical consequences and therapeutic implications
    • Aziz, N. A., Swaab, D. F., Pijl, H. & Roos, R. A. Hypothalamic dysfunction and neuroendocrine and metabolic alterations in Huntington's disease: clinical consequences and therapeutic implications. Rev. Neurosci. 18, 223-251 (2007).
    • (2007) Rev. Neurosci , vol.18 , pp. 223-251
    • Aziz, N.A.1    Swaab, D.F.2    Pijl, H.3    Roos, R.A.4
  • 139
    • 19944427749 scopus 로고    scopus 로고
    • Orexin loss in Huntington's disease
    • Petersen, A. et al. Orexin loss in Huntington's disease. Hum. Mol. Genet. 14, 39-47 (2005).
    • (2005) Hum. Mol. Genet , vol.14 , pp. 39-47
    • Petersen, A.1
  • 140
    • 16044373842 scopus 로고    scopus 로고
    • Exon 1 of the HD gene with an expanded CAG repeat is sufficient to cause a progressive neurological phenotype in transgenic mice
    • Mangiarini, L. et al. Exon 1 of the HD gene with an expanded CAG repeat is sufficient to cause a progressive neurological phenotype in transgenic mice. Cell 87, 493-506 (1996).
    • (1996) Cell , vol.87 , pp. 493-506
    • Mangiarini, L.1
  • 141
    • 33749450755 scopus 로고    scopus 로고
    • Hypocretin-1 (orexin A) levels are normal in Huntington's disease
    • Baumann, C. R., Hersberger, M. & Bassetti, C. L. Hypocretin-1 (orexin A) levels are normal in Huntington's disease. J. Neurol. 253, 1232-1233 (2006).
    • (2006) J. Neurol , vol.253 , pp. 1232-1233
    • Baumann, C.R.1    Hersberger, M.2    Bassetti, C.L.3
  • 142
    • 79958853372 scopus 로고    scopus 로고
    • Functional increase of brain histaminergic signaling in Huntington's disease
    • van Wamelen, D. J. et al. Functional increase of brain histaminergic signaling in Huntington's disease. Brain Pathol. 21, 419-427 (2011).
    • (2011) Brain Pathol , vol.21 , pp. 419-427
    • Van Wamelen, D.J.1
  • 143
    • 79954630031 scopus 로고    scopus 로고
    • Paradoxical function of orexin/hypocretin circuits in a mouse model of Huntington's disease
    • Williams, R. H., Morton, A. J. & Burdakov, D. Paradoxical function of orexin/hypocretin circuits in a mouse model of Huntington's disease. Neurobiol. Dis. 42, 438-445 (2011).
    • (2011) Neurobiol. Dis , vol.42 , pp. 438-445
    • Williams, R.H.1    Morton, A.J.2    Burdakov, D.3
  • 144
    • 12144273983 scopus 로고    scopus 로고
    • Disintegration of the sleep-wake cycle and circadian timing in Huntington's disease
    • Morton, A. J. et al. Disintegration of the sleep-wake cycle and circadian timing in Huntington's disease. J. Neurosci. 25, 157-163 (2005).
    • (2005) J. Neurosci , vol.25 , pp. 157-163
    • Morton, A.J.1
  • 145
    • 84875381701 scopus 로고    scopus 로고
    • Circadian and sleep disorder in Huntington's disease
    • Morton, A. J. Circadian and sleep disorder in Huntington's disease. Exp. Neurol. 243, 34-44 (2013).
    • (2013) Exp. Neurol , vol.243 , pp. 34-44
    • Morton . A, J.1
  • 146
    • 42249109228 scopus 로고    scopus 로고
    • Rapid eye movement sleep disturbances in Huntington disease
    • Arnulf, I. et al. Rapid eye movement sleep disturbances in Huntington disease. Arch. Neurol. 65, 482-488 (2008).
    • (2008) Arch. Neurol , vol.65 , pp. 482-488
    • Arnulf, I.1
  • 147
    • 77952629167 scopus 로고    scopus 로고
    • L-histidine decarboxylase and Tourette's syndrome
    • Ercan-Sencicek, A. G. et al. L-histidine decarboxylase and Tourette's syndrome. N. Engl. J. Med. 362, 1901-1908 (2010).
    • (2010) N. Engl. J. Med , vol.362 , pp. 1901-1908
    • Ercan-Sencicek, A.G.1
  • 148
    • 84890184387 scopus 로고    scopus 로고
    • Support of the histaminergic hypothesis in Tourette syndrome: Association of the histamine decarboxylase gene in a large sample of families
    • Karagiannidis, I. et al. Support of the histaminergic hypothesis in Tourette syndrome: association of the histamine decarboxylase gene in a large sample of families. J. Med. Genet. 50, 760-764 (2013).
    • (2013) J. Med. Genet , vol.50 , pp. 760-764
    • Karagiannidis, I.1
  • 149
    • 84891760813 scopus 로고    scopus 로고
    • Histidine decarboxylase deficiency causes tourette syndrome: Parallel findings in humans and mice
    • Castellan Baldan, L. et al. Histidine decarboxylase deficiency causes tourette syndrome: parallel findings in humans and mice. Neuron 81, 77-90 (2014).
    • (2014) Neuron , vol.81 , pp. 77-90
    • Castellan Baldan, L.1
  • 150
    • 84902441793 scopus 로고    scopus 로고
    • Sleep disorders in children with Tourette syndrome
    • Ghosh, D. et al. Sleep disorders in children with Tourette syndrome. Pediatr. Neurol. 51, 31-35 (2014).
    • (2014) Pediatr. Neurol , vol.51 , pp. 31-35
    • Ghosh, D.1
  • 151
    • 84856716148 scopus 로고    scopus 로고
    • Increasing histamine neurotransmission in Gilles de la Tourette syndrome
    • Hartmann, A., Worbe, Y. & Arnulf, I. Increasing histamine neurotransmission in Gilles de la Tourette syndrome. J. Neurol. 259, 375-376 (2012).
    • (2012) J. Neurol , vol.259 , pp. 375-376
    • Hartmann, A.1    Worbe, Y.2    Arnulf, I.3
  • 152
    • 73249133315 scopus 로고    scopus 로고
    • Histamine antihistamines, and the central nervous system
    • Lieberman, P. Histamine, antihistamines, and the central nervous system. Allergy Asthma Proc. 30, 482-486 (2009).
    • (2009) Allergy Asthma Proc , vol.30 , pp. 482-486
    • Lieberman, P.1
  • 153
    • 84878379048 scopus 로고    scopus 로고
    • Review of the histamine system and the clinical effects of H1 antagonists: Basis for a new model for understanding the effects of insomnia medications
    • Krystal, A. D., Richelson, E. & Roth, T. Review of the histamine system and the clinical effects of H1 antagonists: basis for a new model for understanding the effects of insomnia medications. Sleep Med. Rev. 17, 263-272 (2013).
    • (2013) Sleep Med. Rev , vol.17 , pp. 263-272
    • Krystal, A.D.1    Richelson, E.2    Roth, T.3
  • 154
    • 34548249175 scopus 로고    scopus 로고
    • Efficacy and safety of doxepin 1 mg, 3 mg, and 6 mg in adults with primary insomnia
    • Roth, T. et al. Efficacy and safety of doxepin 1 mg, 3 mg, and 6 mg in adults with primary insomnia. Sleep 30, 1555-1561 (2007).
    • (2007) Sleep , vol.30 , pp. 1555-1561
    • Roth, T.1
  • 155
    • 40849137722 scopus 로고    scopus 로고
    • An inverse agonist of the histamine H(3) receptor improves wakefulness in narcolepsy: Studies in orexin mice and patients
    • Lin, J. S. et al. An inverse agonist of the histamine H(3) receptor improves wakefulness in narcolepsy: studies in orexin mice and patients. Neurobiol. Dis. 30, 74-83 (2008).
    • (2008) Neurobiol. Dis , vol.30 , pp. 74-83
    • Lin, J.S.1
  • 156
    • 84862791691 scopus 로고    scopus 로고
    • Pitolisant, an inverse agonist of the histamine H3 receptor: An alternative stimulant for narcolepsy-cataplexy in teenagers with refractory sleepiness
    • Inocente, C. et al. Pitolisant, an inverse agonist of the histamine H3 receptor: an alternative stimulant for narcolepsy-cataplexy in teenagers with refractory sleepiness. Clin. Neuropharmacol. 35, 55-60 (2012).
    • (2012) Clin. Neuropharmacol , vol.35 , pp. 55-60
    • Inocente, C.1
  • 157
    • 84885378478 scopus 로고    scopus 로고
    • Pitolisant versus placebo or modafinil in patients with narcolepsy: A double-blind, randomised trial
    • Dauvilliers, Y. et al. Pitolisant versus placebo or modafinil in patients with narcolepsy: a double-blind, randomised trial. Lancet Neurol. 12, 1068-1075 (2013).
    • (2013) Lancet Neurol , vol.12 , pp. 1068-1075
    • Dauvilliers, Y.1
  • 158
    • 62549089695 scopus 로고    scopus 로고
    • CSF histamine contents in narcolepsy, idiopathic hypersomnia and obstructive sleep apnea syndrome
    • Kanbayashi, T. et al. CSF histamine contents in narcolepsy, idiopathic hypersomnia and obstructive sleep apnea syndrome. Sleep 32, 181-187 (2009).
    • (2009) Sleep , vol.32 , pp. 181-187
    • Kanbayashi, T.1
  • 159
    • 84875218114 scopus 로고    scopus 로고
    • Unaltered histaminergic system in depression: A postmortem study
    • Shan, L. Qi, X. R., Balesar, R., Swaab, D. F. & Bao, A. M. Unaltered histaminergic system in depression: a postmortem study. J. Affect. Disord. 146, 220-223 (2013).
    • (2013) J. Affect. Disord , vol.146 , pp. 220-223
    • Shan, L.1    Qi, X.R.2    Balesar, R.3    Swaab, D.F.4    Bao, A.M.5
  • 160
    • 84856058121 scopus 로고    scopus 로고
    • Activity-dependent neurotransmitter respecification
    • Spitzer, N. C. Activity-dependent neurotransmitter respecification. Nat. Rev. Neurosci. 13, 94-106 (2012).
    • (2012) Nat. Rev. Neurosci , vol.13 , pp. 94-106
    • Spitzer, N.C.1
  • 161
    • 84872011694 scopus 로고    scopus 로고
    • Functional implications of hypothalamic neurogenesis in the adult mammalian brain
    • Lee, D. A. & Blackshaw, S. Functional implications of hypothalamic neurogenesis in the adult mammalian brain. Int. J. Dev. Neurosci. 30, 615-621 (2012).
    • (2012) Int. J. Dev. Neurosci , vol.30 , pp. 615-621
    • Lee, D.A.1    Blackshaw, S.2
  • 162
    • 78650021224 scopus 로고    scopus 로고
    • Emerging new sites for adult neurogenesis in the mammalian brain: A comparative study between the hypothalamus and the classical neurogenic zones
    • Migaud, M. et al. Emerging new sites for adult neurogenesis in the mammalian brain: a comparative study between the hypothalamus and the classical neurogenic zones. Eur. J. Neurosci. 32, 2042-2052 (2010).
    • (2010) Eur. J. Neurosci , vol.32 , pp. 2042-2052
    • Migaud, M.1
  • 163
    • 84931006064 scopus 로고    scopus 로고
    • Impact of cytokine in type 1 narcolepsy: Role of pandemic H1N1 vaccination?
    • Lecendreux, M. et al. Impact of cytokine in type 1 narcolepsy: role of pandemic H1N1 vaccination? J. Autoimmun. 60, 20-31 (2015).
    • (2015) J. Autoimmun , vol.60 , pp. 20-31
    • Lecendreux, M.1


* 이 정보는 Elsevier사의 SCOPUS DB에서 KISTI가 분석하여 추출한 것입니다.